MXPA04002592A - Uso de extractos de especies de cimicifuga como medicamento organotropico. - Google Patents

Uso de extractos de especies de cimicifuga como medicamento organotropico.

Info

Publication number
MXPA04002592A
MXPA04002592A MXPA04002592A MXPA04002592A MXPA04002592A MX PA04002592 A MXPA04002592 A MX PA04002592A MX PA04002592 A MXPA04002592 A MX PA04002592A MX PA04002592 A MXPA04002592 A MX PA04002592A MX PA04002592 A MXPA04002592 A MX PA04002592A
Authority
MX
Mexico
Prior art keywords
extracts
organoselective
medicines
cimicifuga
treating
Prior art date
Application number
MXPA04002592A
Other languages
English (en)
Inventor
Spengler Barbara
Original Assignee
Bionorica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionorica Ag filed Critical Bionorica Ag
Publication of MXPA04002592A publication Critical patent/MXPA04002592A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invencion se refiere a extractos de especies de Cimicifuga, y en particular de Cimicifuga racemosa, los cuales son adecuados para la produccion de un remedio acabado de formular para el tratamiento y/o profilaxias selectiva de enfermedades del tracto urogenital dependientes de la hormona sexual. Los extractos de conformidad con la invencion son adecuados ademas para el tratamiento y/o la profilaxis de infecciones posmenopausicas de la vejiga urinaria. Son adecuados ademas para tratamiento de hiperplasias benignas y malignas de la prostata.
MXPA04002592A 2001-09-19 2002-09-16 Uso de extractos de especies de cimicifuga como medicamento organotropico. MXPA04002592A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10146159A DE10146159A1 (de) 2001-09-19 2001-09-19 Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
PCT/EP2002/010383 WO2003024465A2 (de) 2001-09-19 2002-09-16 Verwendung von extrakten aus cimicifuga-arten als organselektives arzneimittel

Publications (1)

Publication Number Publication Date
MXPA04002592A true MXPA04002592A (es) 2005-08-26

Family

ID=7699541

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04002592A MXPA04002592A (es) 2001-09-19 2002-09-16 Uso de extractos de especies de cimicifuga como medicamento organotropico.

Country Status (16)

Country Link
US (3) US7413754B2 (es)
EP (1) EP1427430B1 (es)
JP (1) JP2005503404A (es)
KR (1) KR20040041619A (es)
AT (1) ATE293985T1 (es)
AU (1) AU2002362365A1 (es)
BR (1) BR0212598A (es)
DE (2) DE10146159A1 (es)
DK (1) DK1427430T3 (es)
EA (1) EA006164B1 (es)
ES (1) ES2238631T3 (es)
MX (1) MXPA04002592A (es)
PL (1) PL206937B1 (es)
PT (1) PT1427430E (es)
UA (1) UA78228C2 (es)
WO (1) WO2003024465A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1745796A1 (de) 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
DE102007044916A1 (de) * 2007-09-19 2009-04-23 Bionorica Ag Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
MD4025C2 (ro) * 2009-08-25 2010-10-31 Владимир КАРАУШ Remediu pentru tratamentul prostatitei şi hiperplaziei prostatei
KR101303693B1 (ko) 2011-06-30 2013-09-04 한국식품연구원 지방 대사 질환, 폐경기 질환 또는 심혈관질환 개선용 조성물
JP2013010796A (ja) * 2012-10-15 2013-01-17 Kao Corp Ｓ１００ａ８発現調節剤
IT201900000343A1 (it) * 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (ja) 1986-07-23 1988-02-09 Tsumura Juntendo Inc 抗アレルギ−剤
HU204197B (en) 1986-10-30 1991-12-30 Dr Papay Valeria Tothne Process for producing extract for treating aphta, herpes, wounds in the mouth, acne, comedo and pustule
DK0384798T3 (da) 1989-02-06 1993-12-06 Soma Genichiro Limulustest-positivt planteglycolipid samt fremgangsmåde til stimulering af et dyrs immunsystem
US5716646A (en) 1990-05-01 1998-02-10 Smith; Steven A. Methods and compositions for treating arthritis
US5411733A (en) 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
CN1090498A (zh) 1993-02-01 1994-08-10 杨芳林 女用口服避孕中成药及制备方法
JP3501832B2 (ja) 1993-11-15 2004-03-02 一丸ファルコス株式会社 ヒオウギ抽出物を含有するテストステロン５α−リダクターゼ阻害剤とその応用
JP3294694B2 (ja) 1993-11-15 2002-06-24 一丸ファルコス株式会社 ヒオウギ抽出物を含有する細胞賦活剤とその応用
US5569459A (en) 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH0930977A (ja) 1995-07-20 1997-02-04 Tsuneo Nanba 升麻抽出物を含有する骨疾患治療剤
PL186769B1 (pl) 1995-09-07 2004-02-27 Oreal Zastosowanie wyciągu z Iridaceae i kompozycja zawierająca taki wyciąg
DE69600242T2 (de) 1995-09-07 1998-08-06 Oreal Verwendung von Extrakten aus filamentösen, nicht photosynthetischen Bakterien sowie ihre Zusammensetzungen
US6008208A (en) 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
SE9503775L (sv) 1995-10-26 1997-04-27 Caravan Mill Ab Tekniskt förfarande för torkning, krossning och malning av mussel- och snäckskal
US5916565A (en) * 1996-03-08 1999-06-29 In Clover, Inc. Product and method for treating joint disorders in vertebrates
CN1159340A (zh) 1996-03-11 1997-09-17 李城林 一种抗癌抑瘤药物的配方及其制作工艺
JPH107580A (ja) 1996-06-15 1998-01-13 Michio Yoshida コラゲナ−ゼ阻害剤
JP3665848B2 (ja) 1996-09-18 2005-06-29 木村 幸代 ヒメヒオウギズイセン球根抽出液の発酵飲料及びその製造方法
CN1057690C (zh) 1996-10-18 2000-10-25 宁振峰 治疗卵巢癌的中成药
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
US5952374A (en) 1997-09-29 1999-09-14 Protein Technologies International, Inc. Method for inhibiting the development of Alzheimer's disease and related dementias- and for preserving cognitive function
US6039290A (en) 1998-03-16 2000-03-21 Honeywell Inc. Robust singularity avoidance in satellite attitude control
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
US6242012B1 (en) 1999-10-19 2001-06-05 Thomas Newmark Herbal composition for promoting hormonal balance in women and methods of using same
US20010025059A1 (en) * 2000-01-10 2001-09-27 Kastke Floyd A. Composition and method for treating non-bacterial prostatitis
AU2001253070A1 (en) 2000-03-31 2001-10-15 Jonathan Ingram Isoflavones for treatment of obesity
JP2002043945A (ja) 2000-07-19 2002-02-08 Sony Corp ディジタル信号符号化装置及び方法、ディジタル信号復号装置及び方法、並びにディジタル信号伝送システム
US6326366B1 (en) 2000-08-22 2001-12-04 Protein Technologies International Hormone replacement therapy
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
US20020172732A1 (en) 2001-03-21 2002-11-21 Wies Ter Laak Composition comprising cocoa

Also Published As

Publication number Publication date
EP1427430A2 (de) 2004-06-16
US20050019437A1 (en) 2005-01-27
PL370370A1 (en) 2005-05-16
WO2003024465A2 (de) 2003-03-27
DE50202941D1 (de) 2005-06-02
UA78228C2 (en) 2007-03-15
US20080300230A1 (en) 2008-12-04
ES2238631T3 (es) 2005-09-01
PT1427430E (pt) 2005-08-31
US20120071501A1 (en) 2012-03-22
EA006164B1 (ru) 2005-10-27
KR20040041619A (ko) 2004-05-17
US7413754B2 (en) 2008-08-19
ATE293985T1 (de) 2005-05-15
AU2002362365A1 (en) 2003-04-01
PL206937B1 (pl) 2010-10-29
BR0212598A (pt) 2004-10-13
EP1427430B1 (de) 2005-04-27
DK1427430T3 (da) 2005-05-30
EA200400461A1 (ru) 2004-08-26
WO2003024465A3 (de) 2003-10-09
DE10146159A1 (de) 2003-04-10
JP2005503404A (ja) 2005-02-03

Similar Documents

Publication Publication Date Title
DK1420801T3 (da) Anvendelse af fucaner til behandling af adhæsioner, arthritis og psoreasis
ATE376587T1 (de) Granulat mit hoher schlagfestigkeit
AU2003297679A1 (en) Low profile high stretch, low dilation knit prosthetic device
EP1436286A4 (en) FUMAGILLOL DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
TW200716600A (en) Substituted arylpyrazoles
HK1061516A1 (en) Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative
IT1318425B1 (it) Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
WO2002089743A3 (en) Use of compositions for treating rosacea
MY138732A (en) Conjugated complement cascade inhibitors
WO2002011743A3 (en) Treatment of prostate cancer
ECSP045021A (es) Terapia de combinacion para el tratamiento del cancer
MXPA04002592A (es) Uso de extractos de especies de cimicifuga como medicamento organotropico.
HK1057336A1 (en) Pharmaceutical solutions of modafinil compounds
BRPI0411705A (pt) composição, uso da competição, e, uso de pelo menos um extrato de ervas do gênero equisetum e de pelo menos um agente formador de filme
AU2003253498A1 (en) Shower device with tanning device and method for use thereof
AR031505A1 (es) Un producto de cereal y/o legumbre y el procedimiento para prepararlo
CA106650S (en) Lavatory device
WO2002048092A3 (en) Compounds for altering mitochondrial function and cellular responses
BR0103928B1 (pt) equipamento para tratamento de efluentes e estação para tratamento de efluentes.
SV2002000528A (es) Uso de cepas de parapoxvirus ovis para la fabricacion de medicamentos antivirales y medicamentos contra el cancer ref.lea 34376-sv
Sohn et al. 'Beolrae'and Its Symbolism from Korean Modern Novels
AR022625A1 (es) Metodo de transformacion de soja.
HN2000000239A (es) Metodo para tratar el mal de parkinson atraves de la administracion de (-) - 5 - ceto - 2 - n, n - oi - n - propilamino - tetrahidrotetralina.
ES1050192U (es) Calcomania para tatuajes al agua con elementos metalizados.

Legal Events

Date Code Title Description
FG Grant or registration